[
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-12 12:41:27",
    "publisher": "Seeking Alpha",
    "title": "Johnson & Johnson: This Low-Risk, High-Growth, Highly Credible Stock Is A Strong Buy",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-this-lowrisk-highgrowth-highly-credible-stock-is-20220412.jpg",
    "site": "seekingalpha.com",
    "text": "Johnson & Johnson is a healthcare giant, perceived as a global corporate leader having a AAA credit rating, given its high credibility across financial markets.",
    "url": "https://seekingalpha.com/article/4501005-johnson-and-johnson-this-low-risk-high-growth-and-highly-credible-stock-is-a-strong-buy",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-12T12:41:27-04:00",
    "date_et": "2022-04-12"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-12 15:05:59",
    "publisher": "GuruFocus",
    "title": "Will These Pharma Giants Pop or Flop on Clinical Study Readouts?",
    "image": "https://images.financialmodelingprep.com/news/will-these-pharma-giants-pop-or-flop-on-clinical-20220412.jpg",
    "site": "gurufocus.com",
    "text": "Do results from an important clinical trial affect the stock price of pharma companies? We're about to find out, as several readouts are expected in the second quarter.",
    "url": "https://www.gurufocus.com/news/1684389/will-these-pharma-giants-pop-or-flop-on-clinical-study-readouts",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-12T15:05:59-04:00",
    "date_et": "2022-04-12"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-13 07:16:06",
    "publisher": "24/7 Wall Street",
    "title": "5 Elite and Very Safe Dividend Kings Are Also Wall Street Favorites",
    "image": "https://images.financialmodelingprep.com/news/5-elite-and-very-safe-dividend-kings-are-also-20220413.jpg",
    "site": "247wallst.com",
    "text": "At 24/7 Wall St., we know how important dividend size, stability and growth are to growth and income investors who need a dependable stream of income.",
    "url": "https://247wallst.com/investing/2022/04/13/5-elite-and-very-safe-dividend-kings-are-also-wall-street-favorites/",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-13T07:16:06-04:00",
    "date_et": "2022-04-13"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-13 09:47:03",
    "publisher": "Zacks Investment Research",
    "title": "Why Johnson & Johnson (JNJ) Might Surprise This Earnings Season",
    "image": "https://images.financialmodelingprep.com/news/why-johnson-johnson-jnj-might-surprise-this-earnings-season-20220413.jpg",
    "site": "zacks.com",
    "text": "Johnson & Johnson (JNJ) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.",
    "url": "https://www.zacks.com/stock/news/1898487/why-johnson-johnson-jnj-might-surprise-this-earnings-season",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-13T09:47:03-04:00",
    "date_et": "2022-04-13"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-15 05:21:00",
    "publisher": "The Motley Fool",
    "title": "5 Genius Bear Market Investing Strategies",
    "image": "https://images.financialmodelingprep.com/news/5-genius-bear-market-investing-strategies-20220415.jpg",
    "site": "fool.com",
    "text": "Although bear markets can be scary, they're the perfect time to put your money to work.",
    "url": "https://www.fool.com/investing/2022/04/15/5-genius-bear-market-investing-strategies/",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-15T05:21:00-04:00",
    "date_et": "2022-04-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-15 11:45:00",
    "publisher": "The Motley Fool",
    "title": "3 Top Dividend Kings to Buy for the Long Haul",
    "image": "https://images.financialmodelingprep.com/news/3-top-dividend-kings-to-buy-for-the-long-haul-20220415.jpg",
    "site": "fool.com",
    "text": "These three companies bring more to the table than an ever-increasing dividend.",
    "url": "https://www.fool.com/investing/2022/04/15/3-top-dividend-kings-to-buy-for-the-long-haul/",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-15T11:45:00-04:00",
    "date_et": "2022-04-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-16 10:15:00",
    "publisher": "The Motley Fool",
    "title": "2 Top Stocks to Buy in April and Hold Forever",
    "image": "https://images.financialmodelingprep.com/news/2-top-stocks-to-buy-in-april-and-hold-20220416.jpg",
    "site": "fool.com",
    "text": "It is arguably more important than ever to implement the buy-and-hold approach to investing.",
    "url": "https://www.fool.com/investing/2022/04/16/2-top-stocks-to-buy-in-april-and-hold-forever/",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-16T10:15:00-04:00",
    "date_et": "2022-04-16"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-18 09:07:00",
    "publisher": "Reuters",
    "title": "J&J settles with West Virginia on opioid litigation for $99 million",
    "image": "https://images.financialmodelingprep.com/news/jj-settles-with-west-virginia-on-opioid-litigation-for-20220418.jpg",
    "site": "reuters.com",
    "text": "Johnson & Johnson said on Monday it had agreed to pay $99 million to settle opioid-related claims by the state of West Virginia and its subdivisions.",
    "url": "https://www.reuters.com/legal/litigation/jj-settles-with-west-virginia-opioid-litigation-99-mln-2022-04-18/",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-18T09:07:00-04:00",
    "date_et": "2022-04-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-18 10:32:12",
    "publisher": "Zacks Investment Research",
    "title": "J&J (JNJ) to Set the Tone for Pharma Sector's Q1 Earnings",
    "image": "https://images.financialmodelingprep.com/news/jj-jnj-to-set-the-tone-for-pharma-sectors-20220418.jpeg",
    "site": "zacks.com",
    "text": "J&J's (JNJ) Pharma segment is expected to have performed above the market. It remains to be seen if sales improved in the Medical Devices segment in the first quarter.",
    "url": "https://www.zacks.com/stock/news/1901506/j-j-jnj-to-set-the-tone-for-pharma-sector-s-q1-earnings",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-18T10:32:12-04:00",
    "date_et": "2022-04-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-18 13:00:00",
    "publisher": "The Motley Fool",
    "title": "The Safest Healthcare Stocks in the World",
    "image": "https://images.financialmodelingprep.com/news/the-safest-healthcare-stocks-in-the-world-20220418.jpg",
    "site": "fool.com",
    "text": "Stryker, Johnson & Johnson, and Intuitive Surgical can be counted on to be steady performers in your portfolio.",
    "url": "https://www.fool.com/investing/2022/04/18/the-safest-healthcare-stocks-in-the-world/",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-18T13:00:00-04:00",
    "date_et": "2022-04-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-18 14:34:26",
    "publisher": "Invezz",
    "title": "Apple and JNJ are two defensive names. Which is better currently?",
    "image": "https://images.financialmodelingprep.com/news/apple-and-jnj-are-two-defensive-names-which-is-20220418.jpg",
    "site": "invezz.com",
    "text": "Apple Inc (NASDAQ:AAPL) has been regarded as the most defensive stock in times of high volatility. Whereas the stock looked strong in the wake of global supply chain challenges, cracks are emerging from Covid-19 curbs in China.",
    "url": "https://invezz.com/news/2022/04/18/apple-and-jj-are-two-defensive-names-which-is-better-currently/",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-18T14:34:26-04:00",
    "date_et": "2022-04-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-18 16:30:00",
    "publisher": "Stockmarket.com",
    "title": "Best Stocks To Invest In Now? 3 Coronavirus Vaccine Stocks To Know",
    "image": "https://images.financialmodelingprep.com/news/best-stocks-to-invest-in-now-3-coronavirus-vaccine-20220418.jpg",
    "site": "stockmarket.com",
    "text": "Coronavirus vaccine stocks worth knowing as Covid-19 remains a global public health emergency.",
    "url": "https://stockmarket.com/featured/best-stocks-to-invest-in-now-3-coronavirus-vaccine-stocks-to-know-2022-04-18",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-18T16:30:00-04:00",
    "date_et": "2022-04-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-19 06:20:00",
    "publisher": "PRNewsWire",
    "title": "Johnson & Johnson Announces Dividend Increase of 6.6%",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-announces-dividend-increase-of-66-20220419.jpg",
    "site": "prnewswire.com",
    "text": "NEW BRUNSWICK, N.J. , April 19, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 6.6% increase in the quarterly dividend, from $1.06 per share to $1.13 per share.",
    "url": "https://www.prnewswire.com/news-releases/johnson--johnson-announces-dividend-increase-of-6-6-301527648.html",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-19T06:20:00-04:00",
    "date_et": "2022-04-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-19 06:25:00",
    "publisher": "PRNewsWire",
    "title": "Johnson & Johnson Reports Q1 2022 Results",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-reports-q1-2022-results-20220419.jpg",
    "site": "prnewswire.com",
    "text": "Total sales growth of 5.0% to $23.4 Billion with operational growth of 7.7%* and adjusted operational growth of 7.9%* Earnings per share of $1.93 decreasing 16.8% and adjusted earnings per share of $2.67 increasing 3.1%* Company maintaining 2022 full-year guidance for adjusted operational earnings per share and base business operational sales Given global supply surplus and demand uncertainty, the Company is suspending COVID-19 Vaccine sales guidance, with no impact to adjusted operational earnings per share guidance NEW BRUNSWICK, N.J. , April 19, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2022.",
    "url": "https://www.prnewswire.com/news-releases/johnson--johnson-reports-q1-2022-results-301527545.html",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-19T06:25:00-04:00",
    "date_et": "2022-04-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-19 06:26:19",
    "publisher": "Market Watch",
    "title": "J&J boosts dividend to lift implied yield to above 2.5%",
    "image": "https://images.financialmodelingprep.com/news/jj-boosts-dividend-to-lift-implied-yield-to-above-20220419.jpg",
    "site": "marketwatch.com",
    "text": "Johnson & Johnson JNJ, -1.25% said Tuesday it is raising its quarterly dividend by 6.6%, to $1.13 a share from $1.06 a share. The new dividend will be payable June 7 to shareholders of record on May 24.",
    "url": "https://www.marketwatch.com/story/jj-boosts-dividend-to-lift-implied-yield-to-above-25-2022-04-19",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-19T06:26:19-04:00",
    "date_et": "2022-04-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-19 06:35:00",
    "publisher": "Reuters",
    "title": "Johnson & Johnson suspends sales forecast for COVID-19 vaccine",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-suspends-sales-forecast-for-covid19-vaccine-20220419.jpg",
    "site": "reuters.com",
    "text": "(Reuters) -Johnson & Johnson on Tuesday suspended the sales forecast for its COVID-19 vaccine due to global supply surplus and demand uncertainty, sending its shares down 2.6% in premarket trading.",
    "url": "https://www.reuters.com/article/us-johnson-johnson-results/johnson-johnson-suspends-sales-forecast-for-covid-19-vaccine-idUSKCN2MB0NM",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-19T06:35:00-04:00",
    "date_et": "2022-04-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-19 06:37:12",
    "publisher": "Market Watch",
    "title": "J&J stock sinks after revenue misses and full-year outlook was cut, as drug sales disappoint",
    "image": "https://images.financialmodelingprep.com/news/jj-stock-sinks-after-revenue-misses-and-fullyear-outlook-20220419.jpg",
    "site": "marketwatch.com",
    "text": "Shares of Johnson & Johnson JNJ, -1.25% sank 3.2% in premarket trading Tuesday after the pharmaceutical and consumer products company topped first-quarter profit expectations but missed on revenue, and cut its full-year outlook, as the pharmaceuticals business disappointed. Net income fell to $5.15 billion, or $1.93 a share, from $6.20 billion, or $2.32 a share, in the year-ago period.",
    "url": "https://www.marketwatch.com/story/jj-stock-sinks-after-revenue-misses-and-full-year-outlook-was-cut-as-drug-sales-disappoint-2022-04-19",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-19T06:37:12-04:00",
    "date_et": "2022-04-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-19 07:00:23",
    "publisher": "CNBC",
    "title": "J&J lowers 2022 revenue and earnings expectations, stops giving Covid vaccine sales guidance",
    "image": "https://images.financialmodelingprep.com/news/jj-lowers-2022-revenue-and-earnings-expectations-stops-giving-20220419.jpeg",
    "site": "cnbc.com",
    "text": "",
    "url": "https://www.cnbc.com/2022/04/19/covid-and-jnj-earnings-q1-2022.html",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-19T07:00:23-04:00",
    "date_et": "2022-04-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-19 08:07:00",
    "publisher": "The Motley Fool",
    "title": "Interested in Investing in Psychedelics? Check Out This Podcast.",
    "image": "https://images.financialmodelingprep.com/news/interested-in-investing-in-psychedelics-check-out-this-podcast-20220419.jpg",
    "site": "fool.com",
    "text": "And other market news.",
    "url": "https://www.fool.com/investing/2022/04/19/interested-in-investing-in-psychedelics-check-out/",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-19T08:07:00-04:00",
    "date_et": "2022-04-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-19 09:02:09",
    "publisher": "Zacks Investment Research",
    "title": "Johnson & Johnson (JNJ) Tops Q1 Earnings Estimates",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-tops-q1-earnings-estimates-20220419.jpg",
    "site": "zacks.com",
    "text": "Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 2.69% and 1.37%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://www.zacks.com/stock/news/1902031/johnson-johnson-jnj-tops-q1-earnings-estimates",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-19T09:02:09-04:00",
    "date_et": "2022-04-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-19 09:34:51",
    "publisher": "Invezz",
    "title": "J&J Q1 results: there's positive narratives in all three of our segments",
    "image": "https://images.financialmodelingprep.com/news/jj-q1-results-theres-positive-narratives-in-all-three-20220419.jpg",
    "site": "invezz.com",
    "text": "Shares of Johnson & Johnson (NYSE: JNJ) are down 1.0% in premarket trading on Tuesday after the U.S. company reported weaker-than-expected Q1 revenue and lowered its guidance for the future. J&J Q1 financial highlights Net income printed at $5.15 billion that translates to $1.93 per share.",
    "url": "https://invezz.com/news/2022/04/19/jj-q1-results-theres-positive-narratives-in-all-three-of-our-segments/",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-19T09:34:51-04:00",
    "date_et": "2022-04-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-19 09:45:04",
    "publisher": "Benzinga",
    "title": "What's Going On With Johnson & Johnson Stock?",
    "image": "https://images.financialmodelingprep.com/news/whats-going-on-with-johnson-johnson-stock-20220419.jpg",
    "site": "benzinga.com",
    "text": "Johnson & Johnson (NYSE: JNJ) shares are trading higher Tuesday after the company reported mixed financial results and increased its dividend. Johnson & Johnson said first-quarter revenue grew 5% year-over-year to $23.43 billion, which came in below the $23.67 billion estimate.",
    "url": "https://www.benzinga.com/news/earnings/22/04/26686888/whats-going-on-with-johnson-johnson-stock",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-19T09:45:04-04:00",
    "date_et": "2022-04-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-19 10:23:05",
    "publisher": "Seeking Alpha",
    "title": "Johnson & Johnson (JNJ) Management on Q1 2022 Results - Earnings Call Transcript",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-management-on-q1-2022-results-earnings-20220419.jpg",
    "site": "seekingalpha.com",
    "text": "Johnson & Johnson (NYSE:JNJ ) Q1 2022 Earnings Conference Call April 19, 2022 8:30 AM ET Company Participants Joe Wolk - Executive Vice President & Chief Financial Officer Jessica Moore - Vice President of Investor Relations Ashley McEvoy - Executive Vice President & Worldwide Chairman, MedTech Jennifer Taubert - Executive Vice President & Worldwide Chairman, Pharmaceuticals Thibaut Mongon - Executive Vice President & Worldwide Chairman, Consumer Health Conference Call Participants Larry Biegelsen - Wells Fargo Chris Schott - JPMorgan Joanne Wuensch - Citi Chris Shibutani - Goldman Sachs Louise Chen - Cantor Fitzgerald Josh Jennings - Cowen Terence Flynn - Morgan Stanley Matt Miksic - Credit Suisse Geoff Meacham - Bank of America Danielle Antalffy - SVB Leerink Operator Good morning, and welcome to Johnson & Johnson's First Quarter 2022 Earnings Conference Call. All participants will be in listen-only mode until the question-and-answer session of the conference.",
    "url": "https://seekingalpha.com/article/4502130-johnson-and-johnson-jnj-management-on-q1-2022-results-earnings-call-transcript",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-19T10:23:05-04:00",
    "date_et": "2022-04-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-19 10:32:42",
    "publisher": "Schaeffers Research",
    "title": "Johnson & Johnson Stock Hits Post-Earnings Record High",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-stock-hits-postearnings-record-high-20220419.jpg",
    "site": "schaeffersresearch.com",
    "text": "At the top of the Dow this morning sits Johnson & Johnson (NYSE:JNJ), last seen up 3.8% at $184.44 and earlier hitting an all-time high of $184.81.",
    "url": "https://www.schaeffersresearch.com/content/news/2022/04/19/johnson-johnson-stock-hits-post-earnings-record-high",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-19T10:32:42-04:00",
    "date_et": "2022-04-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-19 10:40:57",
    "publisher": "MarketBeat",
    "title": "Workhorse Johnson & Johnson Plows New All-Time Highs",
    "image": "https://images.financialmodelingprep.com/news/workhorse-johnson-johnson-plows-new-alltime-highs-20220419.jpg",
    "site": "marketbeat.com",
    "text": "Johnson & Johnson (NYSE: JNJ) is, if nothing else, a workhorse among stocks and one any investor could own. The company's business is more than entrenched, it often trades at a discount to the S&P 500, it delivers steady consistent growth, and it pays a nice dividend.",
    "url": "https://www.marketbeat.com/originals/workhorse-johnson-and-johnson-plows-new-all-time-highs/?SNAPI",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-19T10:40:57-04:00",
    "date_et": "2022-04-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-19 12:02:13",
    "publisher": "Zacks Investment Research",
    "title": "Housing Data Up for March; JNJ, LMT Mixed in Q1",
    "image": "https://images.financialmodelingprep.com/news/housing-data-up-for-march-jnj-lmt-mixed-in-20220419.jpg",
    "site": "zacks.com",
    "text": "Market indexes are down to start the day, after rallying to near-flat during Monday's regular session.",
    "url": "https://www.zacks.com/stock/news/1902266/housing-data-up-for-march-jnj-lmt-mixed-in-q1",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-19T12:02:13-04:00",
    "date_et": "2022-04-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-19 12:55:39",
    "publisher": "Fox Business",
    "title": "J&J suspends sales forecast for COVID vaccine, cuts profit view",
    "image": "https://images.financialmodelingprep.com/news/jj-suspends-sales-forecast-for-covid-vaccine-cuts-profit-20220419.jpg",
    "site": "foxbusiness.com",
    "text": "Johnson & Johnson on Tuesday said it could no longer provide a forecast for sales of its COVID-19 vaccine, as vaccine hesitancy in low-income countries paired with already low demand in higher-income nations has led to a glut of supply.",
    "url": "https://www.foxbusiness.com/markets/jj-suspends-sales-forecast-covid-vaccine-cuts-profit-view",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-19T12:55:39-04:00",
    "date_et": "2022-04-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-19 13:19:45",
    "publisher": "New York Post",
    "title": "Johnson & Johnson suspends COVID-19 vaccine sales forecast",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-suspends-covid19-vaccine-sales-forecast-20220419.jpg",
    "site": "nypost.com",
    "text": "Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5 billion this year.",
    "url": "https://nypost.com/2022/04/19/johnson-johnson-suspends-covid-19-vaccine-sales-forecast/",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-19T13:19:45-04:00",
    "date_et": "2022-04-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-19 14:11:00",
    "publisher": "Reuters",
    "title": "Alabama settles opioid claims against J&J, distributors for $276 million - attorney general",
    "image": "https://images.financialmodelingprep.com/news/alabama-settles-opioid-claims-against-jj-distributors-for-276-20220419.jpg",
    "site": "reuters.com",
    "text": "Alabama on Tuesday reached $276 million in settlements with Johnson & Johnson, McKesson Corp and Endo Pharmaceutical, resolving the state's claims that the companies fueled an opioid addiction crisis, the state Attorney General said.",
    "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/alabama-settles-opioid-claims-against-jj-distributors-276-mln-attorney-general-2022-04-19/",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-19T14:11:00-04:00",
    "date_et": "2022-04-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-19 19:19:52",
    "publisher": "The Motley Fool",
    "title": "Why Johnson & Johnson Stock Rose Today",
    "image": "https://images.financialmodelingprep.com/news/why-johnson-johnson-stock-rose-today-20220419.jpg",
    "site": "fool.com",
    "text": "Shareholders have larger dividends headed their way.",
    "url": "https://www.fool.com/investing/2022/04/19/why-johnson-johnson-stock-rose-today/",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-19T19:19:52-04:00",
    "date_et": "2022-04-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-20 10:37:54",
    "publisher": "MarketBeat",
    "title": "Highly Valued Abbot Laboratories Could Move Lower",
    "image": "https://images.financialmodelingprep.com/news/highly-valued-abbot-laboratories-could-move-lower-20220420.jpg",
    "site": "marketbeat.com",
    "text": "Abbott Laboratories (NYSE: ABT) is not in danger of losing its business but we have some concerns its share price could fall. Not only is it a highly-valued stock compared to peers but its current revenue and earnings are based largely on COVID-19.",
    "url": "https://www.marketbeat.com/originals/highly-valued-abbot-laboratories-could-move-lower/?SNAPI",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-20T10:37:54-04:00",
    "date_et": "2022-04-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-20 18:13:37",
    "publisher": "CNBC",
    "title": "Jim Cramer names 4 stocks that can endure the Fed's 'aggressive tightening cycle'",
    "image": "https://images.financialmodelingprep.com/news/jim-cramer-names-4-stocks-that-can-endure-the-20220420.jpeg",
    "site": "cnbc.com",
    "text": "\"I'm urging you to consider companies that fit the funnel,\" the \"Mad Money\" host said Wednesday.",
    "url": "https://www.cnbc.com/2022/04/20/jim-cramer-names-4-stocks-that-can-endure-fed-tightening.html",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-20T18:13:37-04:00",
    "date_et": "2022-04-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-21 11:19:17",
    "publisher": "Zacks Investment Research",
    "title": "J&J Sets in Motion Drug/Biotech Q1 Earnings: 3 Stocks to Buy",
    "image": "https://images.financialmodelingprep.com/news/jj-sets-in-motion-drugbiotech-q1-earnings-3-stocks-20220421.jpg",
    "site": "zacks.com",
    "text": "Investors typically look at J&J's (JNJ) results to gauge how the rest of the drug sector will fare.",
    "url": "https://www.zacks.com/stock/news/1904379/j-j-sets-in-motion-drug-biotech-q1-earnings-3-stocks-to-buy",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-21T11:19:17-04:00",
    "date_et": "2022-04-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-21 18:20:11",
    "publisher": "CNBC",
    "title": "These 12 manufacturers can help investors capitalize on the U.S. 'industrial renaissance,' Cramer says",
    "image": "https://images.financialmodelingprep.com/news/these-12-manufacturers-can-help-investors-capitalize-on-the-20220421.jpg",
    "site": "cnbc.com",
    "text": "\"The United States has been reclaiming its industrial preeminence in sector after sector after sector,\" the \"Mad Money\" host said.",
    "url": "https://www.cnbc.com/2022/04/21/jim-cramer-12-us-manufacturers-investors-should-keep-an-eye-on.html",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-21T18:20:11-04:00",
    "date_et": "2022-04-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-23 07:00:00",
    "publisher": "Barron's",
    "title": "Johnson & Johnson, Schlumberger Boosted Dividends",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-schlumberger-boosted-dividends-20220423.jpg",
    "site": "barrons.com",
    "text": "Healthcare giant J&J and oilfield-servicing firm Schlumberger were among the larger firms that declared increased dividends last week.",
    "url": "https://www.barrons.com/articles/johnson-johnson-schlumberger-dividends-51650656026",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-23T07:00:00-04:00",
    "date_et": "2022-04-23"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-25 07:30:00",
    "publisher": "PRNewsWire",
    "title": "Johnson & Johnson Launches Next Satellite Center for Global Health Discovery at Holistic Drug Discovery and Development Centre, University of Cape Town, Focused on Antimicrobial Resistance (AMR)",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-launches-next-satellite-center-for-global-health-20220425.jpg",
    "site": "prnewswire.com",
    "text": "The new Center is focused on outpacing the rising threat of antimicrobial resistance (AMR) and builds on Johnson & Johnson's longstanding commitment to tackle this challenge The Satellite Center in Cape Town is the second site to open in Johnson & Johnson's network of research collaborations aimed at addressing the world's most pressing health challenges The collaboration between Johnson & Johnson and H3D will help to further expand and strengthen Africa's scientific capacity as a global hub for discovery research CAPE TOWN, South Africa , April 25, 2022 /PRNewswire/ -- Johnson & Johnson (the Company) (NYSE: JNJ) today announced the launch of the J&J Satellite Center for Global Health Discovery (Satellite Center) at the Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town, in Cape Town, South Africa. This marks the latest expansion of the J&J Centers for Global Health Discovery (J&J Centers), a global network of research collaborations between the Company and leading research institutions to accelerate translational and discovery research to address some of the world's most pressing global health challenges.",
    "url": "https://www.prnewswire.com/news-releases/johnson--johnson-launches-next-satellite-center-for-global-health-discovery-at-holistic-drug-discovery-and-development-centre-university-of-cape-town-focused-on-antimicrobial-resistance-amr-301531511.html",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-25T07:30:00-04:00",
    "date_et": "2022-04-25"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-25 12:30:00",
    "publisher": "Stockmarket.com",
    "title": "Best Dividend Stocks To Buy Right Now? 5 For Your Watch List",
    "image": "https://images.financialmodelingprep.com/news/best-dividend-stocks-to-buy-right-now-5-for-20220425.jpg",
    "site": "stockmarket.com",
    "text": "Should you consider dividend stocks as market volatility persists?",
    "url": "https://stockmarket.com/featured/best-dividend-stocks-to-buy-right-now-5-for-your-watch-list-2022-04-25",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-25T12:30:00-04:00",
    "date_et": "2022-04-25"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-26 07:40:00",
    "publisher": "The Motley Fool",
    "title": "Is Johnson & Johnson Stock a Buy Now?",
    "image": "https://images.financialmodelingprep.com/news/is-johnson-johnson-stock-a-buy-now-20220426.jpg",
    "site": "fool.com",
    "text": "Another exceptional quarter makes this healthcare stock a solid buy.",
    "url": "https://www.fool.com/investing/2022/04/26/is-johnson-johnson-stock-a-buy-now/",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-26T07:40:00-04:00",
    "date_et": "2022-04-26"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-26 12:47:19",
    "publisher": "Zacks Investment Research",
    "title": "Healthcare ETFs in Focus Ahead of Q1 Earnings",
    "image": "https://images.financialmodelingprep.com/news/healthcare-etfs-in-focus-ahead-of-q1-earnings-20220426.jpg",
    "site": "zacks.com",
    "text": "The healthcare sector has gained some momentum lately on investors' rush to safety in a volatile stock market. The sector is non-cyclical in nature, which in turn, is providing a cushion to the portfolio.",
    "url": "https://www.zacks.com/stock/news/1907964/healthcare-etfs-in-focus-ahead-of-q1-earnings",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-26T12:47:19-04:00",
    "date_et": "2022-04-26"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-26 13:32:36",
    "publisher": "Seeking Alpha",
    "title": "4 Large Caps At New, All-Time Highs",
    "image": "https://images.financialmodelingprep.com/news/4-large-caps-at-new-alltime-highs-20220426.jpg",
    "site": "seekingalpha.com",
    "text": "There are stocks that perform well even when there is a large correction. We have identified four stocks with strong momentum justified by technicals and fundamentals.",
    "url": "https://seekingalpha.com/article/4503659-four-large-caps-at-new-all-time-highs",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-26T13:32:36-04:00",
    "date_et": "2022-04-26"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-26 18:16:00",
    "publisher": "Reuters",
    "title": "J&J sues to block sales of 'dangerous' counterfeit HIV drugs",
    "image": "https://images.financialmodelingprep.com/news/jj-sues-to-block-sales-of-dangerous-counterfeit-hiv-20220426.jpg",
    "site": "reuters.com",
    "text": "Johnson & Johnson has filed a lawsuit against drug distributors and a pharmacy seeking to stop the sale of counterfeit versions of its HIV drugs, months after a similar case brought by Gilead Sciences Inc.",
    "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/jj-sues-block-sales-dangerous-counterfeit-hiv-drugs-2022-04-26/",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-26T18:16:00-04:00",
    "date_et": "2022-04-26"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-28 06:15:22",
    "publisher": "InvestorPlace",
    "title": "7 Long-Term Stocks to Buy for a Robust Retirement",
    "image": "https://images.financialmodelingprep.com/news/7-longterm-stocks-to-buy-for-a-robust-retirement-20220428.jpg",
    "site": "investorplace.com",
    "text": "The amount of years you spend in retirement may vary, yet it's not a bad idea to err on the side of caution. That is, you should build a portfolio that can grow and provide income for 15, 20, perhaps even 30 years.",
    "url": "https://investorplace.com/2022/04/long-term-stocks-7-to-buy-for-a-robust-retirement/",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-28T06:15:22-04:00",
    "date_et": "2022-04-28"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-28 12:02:09",
    "publisher": "Zacks Investment Research",
    "title": "Drug/Biotech Stocks Q1 Earnings Due on Apr 29: BMY, ABBV, AZN",
    "image": "https://images.financialmodelingprep.com/news/drugbiotech-stocks-q1-earnings-due-on-apr-29-bmy-20220428.jpg",
    "site": "zacks.com",
    "text": "Let us take a look at what is in store for BMY, ABBV, and AZN that are scheduled to report on Apr 29.",
    "url": "https://www.zacks.com/stock/news/1910199/drug-biotech-stocks-q1-earnings-due-on-apr-29-bmy-abbv-azn",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-28T12:02:09-04:00",
    "date_et": "2022-04-28"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-29 07:11:00",
    "publisher": "The Motley Fool",
    "title": "Should Investors Be Worried About Tech Stock Valuations?",
    "image": "https://images.financialmodelingprep.com/news/should-investors-be-worried-about-tech-stock-valuations-20220429.jpg",
    "site": "fool.com",
    "text": "Many are quick to call tech stocks overvalued -- but what if the opposite is true?",
    "url": "https://www.fool.com/investing/2022/04/29/should-investors-be-worried-about-tech-stock-valua/",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-29T07:11:00-04:00",
    "date_et": "2022-04-29"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-29 10:32:30",
    "publisher": "Zacks Investment Research",
    "title": "Is Most-Watched Stock Johnson & Johnson (JNJ) Worth Betting on Now?",
    "image": "https://images.financialmodelingprep.com/news/is-mostwatched-stock-johnson-johnson-jnj-worth-betting-on-20220429.jpg",
    "site": "zacks.com",
    "text": "Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "url": "https://www.zacks.com/stock/news/1911494/is-most-watched-stock-johnson-johnson-jnj-worth-betting-on-now",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-29T10:32:30-04:00",
    "date_et": "2022-04-29"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-04-30 08:00:00",
    "publisher": "The Motley Fool",
    "title": "3 Unstoppable Dow Dividend Kings to Boost Your Passive Income Stream",
    "image": "https://images.financialmodelingprep.com/news/3-unstoppable-dow-dividend-kings-to-boost-your-passive-20220430.jpg",
    "site": "fool.com",
    "text": "These dividend stocks are breaking out toward new all-time highs.",
    "url": "https://www.fool.com/investing/2022/04/30/3-unstoppable-dow-dividend-kings-to-boost-your-pas/",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-04-30T08:00:00-04:00",
    "date_et": "2022-04-30"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-05-02 09:52:50",
    "publisher": "24/7 Wall Street",
    "title": "8 Dividend Aristocrat Leaders to Buy Now With the Stock Market Ready to Blow Up",
    "image": "https://images.financialmodelingprep.com/news/8-dividend-aristocrat-leaders-to-buy-now-with-the-20220502.jpg",
    "site": "247wallst.com",
    "text": "The writing is on the wall, and veteran investors know it. Any time you have an almost a 1,000 point move in the venerable Dow Jones industrial average and give it all back the next day like we did late last week, it indicates that fund managers are selling every uptick, and savvy hedge fund portfolio managers are trying to clear as much margin debt as possible.",
    "url": "https://247wallst.com/investing/2022/05/02/8-dividend-aristocrat-leaders-to-buy-now-with-the-stock-market-ready-to-blow-up/",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-05-02T09:52:50-04:00",
    "date_et": "2022-05-02"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-05-02 16:30:00",
    "publisher": "PRNewsWire",
    "title": "Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-to-participate-in-the-bernstein-38th-annual-20220502.jpg",
    "site": "prnewswire.com",
    "text": "NEW BRUNSWICK, N.J. , May 2, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Bernstein 38th Annual Strategic Decisions Conference on Wednesday, June 1 st, at the New York Hilton Midtown in New York.",
    "url": "https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-bernstein-38th-annual-strategic-decisions-conference-301537487.html",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-05-02T16:30:00-04:00",
    "date_et": "2022-05-02"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-05-02 17:34:35",
    "publisher": "The Motley Fool",
    "title": "Why Johnson & Johnson Stock Held Steady in April",
    "image": "https://images.financialmodelingprep.com/news/why-johnson-johnson-stock-held-steady-in-april-20220502.jpg",
    "site": "fool.com",
    "text": "The company's nearly inflation-proof earnings make it attractive to investors.",
    "url": "https://www.fool.com/investing/2022/05/02/why-johnson-johnson-stock-held-steady-in-april/",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-05-02T17:34:35-04:00",
    "date_et": "2022-05-02"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2022-05-03 05:13:00",
    "publisher": "Seeking Alpha",
    "title": "8 Dividend Increases Expected In May 2022",
    "image": "https://images.financialmodelingprep.com/news/8-dividend-increases-expected-in-may-2022-20220503.jpg",
    "site": "seekingalpha.com",
    "text": "We continuously invest in dividend growth stocks to grow our passive income. Earnings projections are being revised downwards to account for the impact inflation is having on costs and continued supply chain issues.",
    "url": "https://seekingalpha.com/article/4506069-8-dividend-increases-expected-in-may-2022",
    "ticker": "JNJ",
    "event_date": "2022-04-19",
    "window_start": "2022-04-12",
    "window_end": "2022-05-03",
    "publishedDateET": "2022-05-03T05:13:00-04:00",
    "date_et": "2022-05-03"
  }
]